Treatment of bleeding irregularities in women with copper-containing IUDs: A systematic review

Contraception

Volumn 87, Issue 5, 2013, Pages 549-566

  Godfrey, Emily M ^a,b   Folger, Suzanne G ^a   Jeng, Gary ^a   Jamieson, Denise J ^a   Curtis, Kathryn M ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Abnormal bleeding; Contraception; Intrauterine contraception; Intrauterine device; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ALCLOFENAC; APROTININ; COPPER INTRAUTERINE DEVICE; DESMOPRESSIN; DICLOFENAC; DIURETIC AGENT; FLUFENAMIC ACID; IBUPROFEN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SUPROFEN; TOLFENAMIC ACID; TRANEXAMIC ACID;

ABDOMINAL DISCOMFORT; CLINICAL EFFECTIVENESS; DIURETIC THERAPY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG WITHDRAWAL; FATIGUE; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABILITY; LEG EDEMA; MENORRHAGIA; MENSTRUATION DISORDER; REVIEW; SIDE EFFECT; SPOTTING; SWEATING; SYSTEMATIC REVIEW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIFIBRINOLYTIC AGENTS; FEMALE; HUMANS; INTRAUTERINE DEVICES, COPPER; MENORRHAGIA; METRORRHAGIA;

EID: 84876664229     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.09.006     Document Type: Review

References (36)

1. C. d'Arcangues Worldwide use of intrauterine devices for contraception Contraception 75 2007 S2 S7
2. W.D. Mosher, and J. Jones Use of contraception in the United States: 1982-2008 Vital Health Stat 23 2010 1 44
3. I. Sivin Utility and drawbacks of continuous use of a copper T IUD for 20 years Contraception 75 2007 S70 S75
4. R. Kulier, P.A. O'Brien, F.M. Helmerhorst, M. Usher-Patel, and C. D'Arcangues Copper containing, framed intra-uterine devices for contraception Cochrane Database Syst Rev 2007 CD005347
5. I. Sivin, J. Stern, and S. Diaz Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices Am J Obstet Gynecol 166 1992 1208 1213
6. A.T. Andrade, E. Pizarro, and S.T. Shaw Jr. Consequences of uterine blood loss caused by various intrauterine contraceptive devices in South American women. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction Contraception 38 1988 1 18
7. O. Ylikorkala Prostaglandin synthesis inhibitors in menorrhagia, intrauterine contraceptive device-induced side effects and endometriosis Pharmacol Toxicol 75 Suppl. 2 1994 86 88 (Pubitemid 24288323)
8. D.A. Grimes, D. Hubacher, L.M. Lopez, and K.F. Schulz Non-steroidal anti-inflammatory drugs for heavy bleeding or pain associated with intrauterine-device use Cochrane Database Syst Rev 2006 CD006034
9. World Health Organization Selected practice recommendations for contraception use 2nd ed 2004 WHO Geneva
10. J. Newton, G. Barnard, and W. Collins A rapid method for measuring menstrual blood loss using automatic extraction Contraception 16 1977 269 282 (Pubitemid 8185987)
11. J.M. Higham, P.M. O'Brien, and R.W. Shaw Assessment of menstrual blood loss using a pictorial chart Br J Obstet Gynaecol 97 1990 734 739 (Pubitemid 20263124)
12. A.P. Mohllajee, K.M. Curtis, and R.G. Flanagan Keeping up with evidence a new system for WHO's evidence-based family planning guidance Am J Prev Med 28 2005 483 490 (Pubitemid 40723585)
13. R.P. Harris, M. Helfand, and S.H. Woolf Current methods of the US Preventive Services Task Force: A review of the process Am J Prev Med 20 2001 21 35 (Pubitemid 33732964)
14. E. Pizarro, G. Mehech, M. Hidalgo, G. Munoz, and C. Romero Effect of meclofenamic acid on menstruation in hypermenorrheic women using intrauterine devices Rev Chil Obstet Ginecol 53 1988 43 56
15. N. Pedron, M. Lozano, and R. Aznar Treatment of hypermenorrhea with mefenamic acid in women using IUDs Contracept Deliv Syst 3 1982 135 139
16. M. Blum, and J. Pery Prevention of iron deficiency anemia in IUD users by prostaglandin synthetase inhibitors Contracept Deliv Syst 5 1984 21 23
17. P.F. Tauber, A.S. Wolf, W. Herting, and L.J. Zaneveld Hemorrhage induced by intrauterine devices: control by local proteinase inhibition Fertil Steril 28 1977 1375 1377 (Pubitemid 8257810)
18. M. Toppozada, M. Anwar, H. Abdel Rahman, and S. Gaweesh Control of IUD-induced bleeding by three non-steroidal anti-inflammatory drugs Contracept Deliv Syst 3 1982 117 125
19. A. Di Lieto, D. Catalano, L. Miranda, and A. Paladini Action of a prostaglandin synthetase inhibitor on IUD associated uterine bleeding Clin Exp Obstet Gynecol 14 1987 41 44 (Pubitemid 17231110)
20. M. Toppozada, A. El-Attar, M.A. El-Ayyat, and Y. Khamis Management of uterine bleeding by PGs or their synthesis inhibitors Adv Prostaglandin Thromboxane Res 8 1980 1459 1463
21. Chinese National IUD Research Working Group. [Prevention and treatment of IUD-induced menorrhagia with antifibrinolytic and antiprostaglandin drugs]. Zhonghua Fu Chan Ke Za Zhi 1987;22:291-4,3
22. F. Mercorio, R. De Simone, and C. Di Carlo Effectiveness and mechanism of action of desmopressin in the treatment of copper intrauterine device-related menorrhagia: A pilot study Hum Reprod 18 2003 2319 2322 (Pubitemid 37427811)
23. S. Wu, C. Wang, and W. Cheng Randomized multi-center study of baofuxin for treatment of bleeding side-effect induced by IUD Reprod Contracep 11 2000 152 157
24. O. Ylikorkala, and L. Viinikka Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices Br J Obstet Gynaecol 90 1983 78 83 (Pubitemid 13224187)
25. N. Pedron, M. Lozano, and A.J. Gallegos The effect of acetylsalicylic acid on menstrual blood loss in women with IUDs Contraception 36 1987 295 303 (Pubitemid 17153547)
26. D. Hubacher, V. Reyes, and S. Lillo Preventing copper intrauterine device removals due to side effects among first-time users: randomized trial to study the effect of prophylactic ibuprofen Hum Reprod 21 2006 1467 1472 (Pubitemid 44445023)
27. L. Makarainen, and O. Ylikorkala Ibuprofen prevents IUCD-induced increases in menstrual blood loss Br J Obstet Gynaecol 93 1986 285 288 (Pubitemid 16111959)
28. S. Roy, and S.T. Shaw Jr. Role of prostaglandins in IUD-associated uterine bleeding - effect of a prostaglandin synthetase inhibitor (ibuprofen) Obstet Gynecol 58 1981 101 106 (Pubitemid 11086870)
29. O. Ylikorkala, A. Kauppila, and M. Siljander Anti-prostglandin therapy in prevention of side-effects of intrauterine contraceptive devices Lancet 2 1978 393 395 (Pubitemid 9010904)
30. X. Lin, E.S. Gao, and D. Li Preventive treatment of intrauterine device-induced menstrual blood loss with tranexamic acid in Chinese women Acta Obstet Gynecol Scand 86 2007 1126 1129 (Pubitemid 47345792)
31. UBM Medica. Transamin - detailed prescribing information. 2011. Available at: http://www.mims.com.vn/Malaysia/drug/info/Transamin/?type=full#Manufacturer [Last accessed March 27, 2012].
32. World Health Organization. WHO model list of essential medicines, 17th list. 2011. Available at: http://whqlibdoc.who.int/hq/2011/a95053-eng.pdf [Last accessed March 27, 2012].
33. Food and Drug Administration Lysteda (tranexamic acid) tables: highlights of prescribing information http://www.accessdata.fda.gov/drugsatfda-docs/label/ 2011/022430s002lbl.pdf 2011 Available at, [Last accessed March 27, 2012]
34. D. Henry, P. Carless, D. Fergusson, and A. Laupacis The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: A meta-analysis CMAJ 180 2009 183 193
35. A. Lethaby, C. Augood, K. Duckitt, and C. Farquhar Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding Cochrane Database Syst Rev 2007 CD000400
36. M. Edlund Nonhormonal treatments for heavy menstrual bleeding J Womens Health (Larchmt) 20 2011 1645 1653